Literature DB >> 15043988

Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients.

Hiroshi Yamazaki1, Masaki Fujieda, Masahiro Togashi, Tetsuya Saito, George Preti, John R Cashman, Tetsuya Kamataki.   

Abstract

Trimethylaminuria (TMAU) is a metabolic disorder characterized by the inability to oxidize and convert dietary-derived trimethylamine (TMA) to trimethylamine N-oxide (TMAO). This disorder has been relatively well-documented in European and North American populations, but no reports have appeared regarding patients in Japan. We identified seven Japanese individuals that showed a low metabolic capacity to convert TMA to its odorless metabolite, TMAO. The metabolic capacity, as defined by the concentration of TMAO excreted in the urine divided by TMA concentration plus TMAO concentration, in these seven individuals ranged from 70 to 90%. In contrast, there were no healthy controls examined with less than 95% of the metabolic capacity to convert TMA to TMAO. The intake of dietary charcoal (total 1.5 g charcoal per day for 10 days) reduced the urinary free TMA concentration and increased the concentration of TMAO to normal values during charcoal administration. Copper chlorophyllin (total 180 mg per day for 3 weeks) was also effective at reducing free urinary TMA concentration and increasing TMAO to those of concentrations present in normal individuals. In the TMAU subjects examined, the effects of copper chlorophyllin appeared to last longer (i.e., several weeks) than those observed for activated charcoal. The results suggest that the daily intake of charcoal and/or copper chlorophyllin may be of significant use in improving the quality of life of individuals suffering from TMAU.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15043988     DOI: 10.1016/j.lfs.2003.10.022

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  20 in total

1.  Clinical utility gene card for: trimethylaminuria.

Authors:  Elizabeth A Shephard; Eileen P Treacy; Ian R Phillips
Journal:  Eur J Hum Genet       Date:  2011-11-30       Impact factor: 4.246

2.  Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.

Authors:  Makiko Shimizu; Charles K Allerston; Elizabeth A Shephard; Hiroshi Yamazaki; Ian R Phillips
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

3.  Effect of pregnancy on a measure of FMO3 activity.

Authors:  Janne Hukkanen; Delia Dempsey; Peyton Jacob; Neal L Benowitz
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

4.  Attenuation of acridine mutagen ICR-191--DNA interactions and DNA damage by the mutagen interceptor chlorophyllin.

Authors:  Monika Pietrzak; H Dorota Halicka; Zbigniew Wieczorek; Jolanta Wieczorek; Zbigniew Darzynkiewicz
Journal:  Biophys Chem       Date:  2008-03-30       Impact factor: 2.352

Review 5.  Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.

Authors:  Sharon K Krueger; David E Williams
Journal:  Pharmacol Ther       Date:  2005-06       Impact factor: 12.310

6.  Transient massive trimethylaminuria associated with food protein-induced enterocolitis syndrome.

Authors:  Natalie B Miller; Avraham Beigelman; Elizabeth Utterson; Marwan Shinawi
Journal:  JIMD Rep       Date:  2013-07-03

7.  Trimethylaminuria: causes and diagnosis of a socially distressing condition.

Authors:  Richard J Mackay; Christopher J McEntyre; Caroline Henderson; Michael Lever; Peter M George
Journal:  Clin Biochem Rev       Date:  2011-02

8.  Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children.

Authors:  R A Chalmers; M D Bain; H Michelakakis; J Zschocke; R A Iles
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

9.  Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.

Authors:  Meike S Motika; Jun Zhang; Xueying Zheng; Kiersten Riedler; John R Cashman
Journal:  Mol Genet Metab       Date:  2009-02-27       Impact factor: 4.797

Review 10.  A review of trimethylaminuria: (fish odor syndrome).

Authors:  Jeffrey Messenger; Shane Clark; Susan Massick; Mark Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.